Alzheimer's Drug Available, But Sales Slow — VOA Learning English
Topics: подорожі й побут
Beginning
From VOA Learning English, this is the Health & Lifestyle report.
Alzheimer’s disease affects a person’s memory, thinking and behavior. The first drug shown to slow the effects of Alzheimer’s disease reached the market in the United States over a year ago. However, sales of the drug Leqembi have been slow.
Reasons for slow sales
Major hospital systems in the U.S. have taken months to start using the new Alzheimer’s drug. Some health insurers have rejected paying for the medication. And doctors say they expect some patients will be slow to take Leqembi because of the drug’s limited results and possible side effects.
Doctors say it will take years to learn how best to use the drug. They add that…
Tap any word for its translation at once; the word goes into your deck together with its sentence.